Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?
Recruitment status was: Recruiting
Patients with hemolytic disorders (e.g. sickle cell anemia or thalassemia) are known to develop pulmonary hypertension. Hemolysis is where red blood cells are destroyed and their contents released into the circulation. It is thought that these red-cell contents cause constriction and thrombosis of the blood vessels in the lungs. Conversely, it is possible that patients with pulmonary hypertension have hemolysis.
In this study we will be drawing blood from a range of patients and normal controls for a panel of blood tests related to hemolysis.
|Study Design:||Time Perspective: Prospective|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00502398
|Contact: Ben Fox, MRCP||+972 3 937 email@example.com|
|Pulmonary Institute, Rabin Medical Center (Beilinson campus)||Recruiting|
|Petach Tikva, Israel, 49100|
|Contact: Ben Fox, MRCP firstname.lastname@example.org|
|Principal Investigator:||Mordechai Kramer, MD||Rabin Medical Center|